Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma
2025 · Annals of Allergy Asthma & Immunology · 7 citations
https://doi.org/10.1016/j.anai.2025.01.002
P
Peter A. Howarth
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
2.3K
Citations
21
h-index
32
i10-index
Peter A. Howarth is an academic researcher from Amnesty International. The author has contributed to research in topics: Visual perception and processing mechanisms & Virtual Reality Applications and Impacts & Ergonomics and Musculoskeletal Disorders. The author has an h-index of 21, co-authored 68 publications.
ORCID: 0000-0002-0745-019XPapers by this author
worksLow Adherence to Current Biologic Therapies in Asthma: Insights From a Retrospective Cohort Analysis of Claims Data
2025 · Journal of Allergy and Clinical Immunology · 2 citations
https://doi.org/10.1016/j.jaci.2024.12.1009
Mepolizumab Improves and Sustains Clinical Benefits in Patients With Severe Asthma, Independent of Blood Eosinophil Count at Baseline: Real-World Analysis of REALITI-A Results at 2 Years
2025 · Journal of Allergy and Clinical Immunology · 0 citations
https://doi.org/10.1016/j.jaci.2024.12.717
EVOLUTION OF ASTHMA PATIENTS IN RANDOMIZED CLINICAL TRIALS SETTING ALONGSIDE THE CHANGING LANDSCAPE OF BIOLOGIC USE: A COMPARATIVE ASSESSMENT
2025 · CHEST Journal · 0 citations
https://doi.org/10.1016/j.chest.2025.07.036
PCR138 Increased Adherence to Biologic Therapies Leads to Lower All-Cause and Asthma-Related (HCRU) Costs in Severe Asthma
2025 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2025.09.2611
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat